Izotropic Reschedules Investor Conference Presentation to March 13th

Vancouver, British Columbia and Sacramento, California–(Newsfile Corp. – February 5, 2025) – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company“), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers, announces it is rescheduling its attendance and presentation at the OTC’s Virtual Investor Conference from Thursday February 6th to Thursday March 13th, 2025.

Due to a family emergency, the CEO is no longer available to present at the conference as originally scheduled and will instead present at the OTC’s Life Science Virtual Investor Forum on March 13th. The Company will announce the registration link when it becomes available.

Those with one-on-one meetings scheduled with the CEO this week will be contacted directly to reschedule, or may do so at the following link: https://calendly.com/izotropic/meeting-with-ceo

The Company’s business plans and progress are not affected, and the CEO will resume normal course business next week.

The Company thanks everyone for their understanding.

About Izotropic:

More information about Izotropic Corporation can be found on its website at izocorp.com and by reviewing its profile on SEDAR at sedarplus.ca.

Forward-Looking Statements:

This document may contain statements that are “Forward-Looking Statements,” which are based upon the current estimates, assumptions, projections, and expectations of the Company’s management, business, and its knowledge of the relevant market and economic environment in which it operates. The Company has tried, where possible, to identify such information and statements by using words such as “anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” “contemplate” and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words.

These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company’s activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView has not yet been approved or cleared for sale.

Contacts:

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239854